Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd. (PHH) Financial Performance & Income Statement Overview
Review Park Ha Biological Technology Co., Ltd. (PHH) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Park Ha Biological Technology Co., Ltd. (PHH) Income Statement & Financial Overview
View the income breakdown for Park Ha Biological Technology Co., Ltd. PHH across both annual and quarterly reports.
| Metric | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $35.00M | $50.00M | $109.00M | $121.00M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $35.00M | $50.00M | $109.00M | $121.00M |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $28.00M | $32.00M | $50.00M | $84.00M |
| Operating Expenses | -$69.00M | -$80.00M | -$134.00M | -$212.00M |
| Total Costs & Expenses | -$69.00M | -$80.00M | -$134.00M | -$212.00M |
| Interest Income | $4.00M | $3.00M | -$13.00M | $10.00M |
| Interest Expense | $15.00M | $17.00M | $20.00M | $20.00M |
| Depreciation & Amortization | $2.00M | $3.00M | $3.00M | $4.00M |
| EBITDA | -$32.00M | -$27.00M | -$22.00M | -$87.00M |
| EBITDA Ratio | -$0.91 | -$0.54 | -$0.20 | -$0.72 |
| Operating Income | -$34.00M | -$30.00M | -$25.00M | -$91.00M |
| Operating Income Ratio | -$0.97 | -$0.60 | -$0.23 | -$0.75 |
| Other Income/Expenses (Net) | $8.00M | -$156.00M | -$250.00M | $13.00M |
| Income Before Tax | -$36.00M | -$26.00M | -$7.00M | -$78.00M |
| Income Before Tax Ratio | -$1.03 | -$0.52 | -$0.06 | -$0.64 |
| Income Tax Expense | $1.00M | $4.00M | $24.00M | -$36.00M |
| Net Income | -$37.00M | -$30.00M | -$31.00M | -$42.00M |
| Net Income Ratio | -$1.06 | -$0.60 | -$0.28 | -$0.35 |
| EPS | -$1.13 | -$0.92 | -$0.95 | -$0.87 |
| Diluted EPS | -$1.13 | -$0.92 | -$0.95 | -$0.87 |
| Weighted Avg Shares Outstanding | $32.67M | $32.65M | $32.63M | $48.21M |
| Weighted Avg Shares Outstanding (Diluted) | $32.67M | $32.65M | $32.63M | $48.21M |
Over the last four quarters, Park Ha Biological Technology Co., Ltd.'s revenue moved from $121.00M in Q3 2017 to $35.00M in Q2 2018. Operating income in Q2 2018 was -$34.00M, with a strong operating margin of -97%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Park Ha Biological Technology Co., Ltd. remained robust at -$32.00M, reflecting operational efficiency. Net income dropped to -$37.00M, with an EPS of -$1.13. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan